These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 10466474

  • 1. Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia.
    Lopatin DA, Ailamazian EK, Dmitrieva RI, Shpen VM, Fedorova OV, Doris PA, Bagrov AY.
    J Hypertens; 1999 Aug; 17(8):1179-87. PubMed ID: 10466474
    [Abstract] [Full Text] [Related]

  • 2. Cicletanine reverses vasoconstriction induced by the endogenous sodium pump ligand, marinobufagenin, via a protein kinase C dependent mechanism.
    Bagrov AY, Dmitrieva RI, Dorofeeva NA, Fedorova OV, Lopatin DA, Lakatta EG, Droy-Lefaix MT.
    J Hypertens; 2000 Feb; 18(2):209-15. PubMed ID: 10694190
    [Abstract] [Full Text] [Related]

  • 3. Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats.
    Fedorova OV, Kolodkin NI, Agalakova NI, Lakatta EG, Bagrov AY.
    Hypertension; 2001 Feb; 37(2 Pt 2):462-6. PubMed ID: 11230319
    [Abstract] [Full Text] [Related]

  • 4. Interaction of Digibind with endogenous cardiotonic steroids from preeclamptic placentae.
    Fedorova OV, Tapilskaya NI, Bzhelyansky AM, Frolova EV, Nikitina ER, Reznik VA, Kashkin VA, Bagrov AY.
    J Hypertens; 2010 Feb; 28(2):361-6. PubMed ID: 19927009
    [Abstract] [Full Text] [Related]

  • 5. Effects of two putative endogenous digitalis-like factors, marinobufagenin and ouabain, on the Na+, K+-pump in human mesenteric arteries.
    Bagrov AY, Fedorova OV.
    J Hypertens; 1998 Dec; 16(12 Pt 2):1953-8. PubMed ID: 9886882
    [Abstract] [Full Text] [Related]

  • 6. Endogenous Na,K pump ligands are differentially regulated during acute NaCl loading of Dahl rats.
    Fedorova OV, Lakatta EG, Bagrov AY.
    Circulation; 2000 Dec 12; 102(24):3009-14. PubMed ID: 11113054
    [Abstract] [Full Text] [Related]

  • 7. Endogenous marinobufagenin-like immunoreactive substance. A possible endogenous Na, K-ATPase inhibitor with vasoconstrictor activity.
    Bagrov AY, Dmitrieva RI, Fedorova OV, Kazakov GP, Roukoyatkina NI, Shpen VM.
    Am J Hypertens; 1996 Oct 12; 9(10 Pt 1):982-90. PubMed ID: 8896650
    [Abstract] [Full Text] [Related]

  • 8. Endogenous ligand of alpha(1) sodium pump, marinobufagenin, is a novel mediator of sodium chloride--dependent hypertension.
    Fedorova OV, Talan MI, Agalakova NI, Lakatta EG, Bagrov AY.
    Circulation; 2002 Mar 05; 105(9):1122-7. PubMed ID: 11877366
    [Abstract] [Full Text] [Related]

  • 9. Endogenous marinobufagenin-like factor in acute plasma volume expansion.
    Fedorova OV, Doris PA, Bagrov AY.
    Clin Exp Hypertens; 1998 Mar 05; 20(5-6):581-91. PubMed ID: 9682914
    [Abstract] [Full Text] [Related]

  • 10. Antibody to Marinobufagenin Reverses Placenta-Induced Fibrosis of Umbilical Arteries in Preeclampsia.
    Fedorova OV, Ishkaraeva VV, Grigorova YN, Reznik VA, Kolodkin NI, Zazerskaya IE, Zernetkina V, Agalakova NI, Tapilskaya NI, Adair CD, Lakatta EG, Bagrov AY.
    Int J Mol Sci; 2018 Aug 13; 19(8):. PubMed ID: 30104471
    [Abstract] [Full Text] [Related]

  • 11. Phorbol diacetate potentiates na(+)-k(+) ATPase inhibition by a putative endogenous ligand, marinobufagenin.
    Fedorova OV, Dorofeeva NA, Lopatin DA, Lakatta EG, Bagrov AY.
    Hypertension; 2002 Feb 13; 39(2):298-302. PubMed ID: 11847201
    [Abstract] [Full Text] [Related]

  • 12. Endogenous Na/K-ATPase inhibitors in patients with preeclampsia.
    Averina IV, Tapilskaya NI, Reznik VA, Frolova EV, Fedorova OV, Lakatta EG, Bagrov AY.
    Cell Mol Biol (Noisy-le-grand); 2006 Dec 30; 52(8):19-23. PubMed ID: 17535731
    [Abstract] [Full Text] [Related]

  • 13. Monoclonal antibody to an endogenous bufadienolide, marinobufagenin, reverses preeclampsia-induced Na/K-ATPase inhibition and lowers blood pressure in NaCl-sensitive hypertension.
    Fedorova OV, Simbirtsev AS, Kolodkin NI, Kotov AY, Agalakova NI, Kashkin VA, Tapilskaya NI, Bzhelyansky A, Reznik VA, Frolova EV, Nikitina ER, Budny GV, Longo DL, Lakatta EG, Bagrov AY.
    J Hypertens; 2008 Dec 30; 26(12):2414-25. PubMed ID: 19008721
    [Abstract] [Full Text] [Related]

  • 14. Endogenous cardiotonic steroids in chronic renal failure.
    Kolmakova EV, Haller ST, Kennedy DJ, Isachkina AN, Budny GV, Frolova EV, Piecha G, Nikitina ER, Malhotra D, Fedorova OV, Shapiro JI, Bagrov AY.
    Nephrol Dial Transplant; 2011 Sep 30; 26(9):2912-9. PubMed ID: 21292813
    [Abstract] [Full Text] [Related]

  • 15. Marinobufagenin, an endogenous ligand of alpha-1 sodium pump, is a marker of congestive heart failure severity.
    Fridman AI, Matveev SA, Agalakova NI, Fedorova OV, Lakatta EG, Bagrov AY.
    J Hypertens; 2002 Jun 30; 20(6):1189-94. PubMed ID: 12023690
    [Abstract] [Full Text] [Related]

  • 16. Plasma marinobufagenin-like and ouabain-like immunoreactivity during saline volume expansion in anesthetized dogs.
    Bagrov AY, Fedorova OV, Dmitrieva RI, French AW, Anderson DE.
    Cardiovasc Res; 1996 Feb 30; 31(2):296-305. PubMed ID: 8730407
    [Abstract] [Full Text] [Related]

  • 17. DigiFab interacts with endogenous cardiotonic steroids and reverses preeclampsia-induced Na/K-ATPase inhibition.
    Ishkaraeva-Yakovleva VV, Fedorova OV, Solodovnikova NG, Frolova EV, Bzhelyansky AM, Emelyanov IV, Adair CD, Zazerskaya IE, Bagrov AY.
    Reprod Sci; 2012 Dec 30; 19(12):1260-7. PubMed ID: 22649120
    [Abstract] [Full Text] [Related]

  • 18. Antibody against Na/K-ATPase Inhibitor Lowers Blood Pressure and Increases Vascular Fli1 in Experimental Preeclampsia.
    Agalakova NI, Reznik VA, Nadei OV, Ershov IA, Rassokha OS, Vasyutina ML, Ivanov DO, Adair CD, Galagudza MM, Bagrov AY.
    Am J Hypertens; 2020 May 21; 33(6):514-519. PubMed ID: 31713584
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of Na/K ATPase from rat aorta by two Na/K pump inhibitors, ouabain and marinobufagenin: evidence of interaction with different alpha-subunit isoforms.
    Fedorova OV, Bagrov AY.
    Am J Hypertens; 1997 Aug 21; 10(8):929-35. PubMed ID: 9270089
    [Abstract] [Full Text] [Related]

  • 20. Plasma marinobufagenin-like and ouabain-like immunoreactivity in adrenocorticotropin-treated rats.
    Fedorova OV, Anderson DE, Bagrov AY.
    Am J Hypertens; 1998 Jul 21; 11(7):796-802. PubMed ID: 9683040
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.